{"id":"https://openalex.org/W2603578455","doi":"https://doi.org/10.1200/jco.2017.35.4_suppl.315","title":"Phase I study of gemcitabine (G), dasatinib (D), and erlotinib (E) in advanced pancreatic carcinoma (PC).","display_name":"Phase I study of gemcitabine (G), dasatinib (D), and erlotinib (E) in advanced pancreatic carcinoma (PC).","publication_year":2017,"publication_date":"2017-02-01","ids":{"openalex":"https://openalex.org/W2603578455","doi":"https://doi.org/10.1200/jco.2017.35.4_suppl.315","mag":"2603578455"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2017.35.4_suppl.315","doi":"https://doi.org/10.1200/jco.2017.35.4_suppl.315","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2017.35.4_suppl.315","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010469485","display_name":"Dana Backlund Cardin","orcid":"https://orcid.org/0000-0002-0269-9615","observed_orcids":["https://orcid.org/0000-0002-0269-9615"]},"institutions":[{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dana Backlund Cardin","raw_affiliation_strings":["Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN;","institution_ids":["https://openalex.org/I4390039299","https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088976086","display_name":"Laura Williams Goff","orcid":"https://orcid.org/0000-0001-6719-1479","observed_orcids":["https://orcid.org/0000-0001-6719-1479"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laura Williams Goff","raw_affiliation_strings":["Vanderbilt University Medical Center, Nashville, TN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Medical Center, Nashville, TN;","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088841234","display_name":"Emily W. Chan","orcid":"https://orcid.org/0000-0001-9458-3080","observed_orcids":["https://orcid.org/0000-0001-9458-3080"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Emily Chan","raw_affiliation_strings":["Vanderbilt University Medical Center, Nashville, TN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Medical Center, Nashville, TN;","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075392197","display_name":"Jennifer G. Whisenant","orcid":"https://orcid.org/0000-0002-3435-2464","observed_orcids":["https://orcid.org/0000-0002-3435-2464"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Whisenant","raw_affiliation_strings":["Vanderbilt, Nashville, TN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt, Nashville, TN;","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073974051","display_name":"Lori R. Arlinghaus","orcid":"https://orcid.org/0000-0002-8582-1777","observed_orcids":["https://orcid.org/0000-0002-8582-1777"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lori R. Arlinghaus","raw_affiliation_strings":["Vanderbilt University Institute of Imaging Science, Nashville, TN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Institute of Imaging Science, Nashville, TN;","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027619317","display_name":"Thomas E. Yankeelov","orcid":"https://orcid.org/0000-0001-6201-3913","observed_orcids":["https://orcid.org/0000-0001-6201-3913"]},"institutions":[{"id":"https://openalex.org/I86519309","display_name":"The University of Texas at Austin","ror":"https://ror.org/00hj54h04","country_code":"US","type":"education","lineage":["https://openalex.org/I86519309"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas Yankeelov","raw_affiliation_strings":["The University of Texas at Austin, Austin, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas at Austin, Austin, TX;","institution_ids":["https://openalex.org/I86519309"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048600723","display_name":"Tatsuki Koyama","orcid":"https://orcid.org/0000-0002-8908-9165","observed_orcids":["https://orcid.org/0000-0002-8908-9165"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tatsuki Koyama","raw_affiliation_strings":["School of Medicine, Vanderbilt University, Nashville, TN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Medicine, Vanderbilt University, Nashville, TN;","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039492614","display_name":"Jordan D. Berlin","orcid":"https://orcid.org/0000-0001-7571-2385","observed_orcids":["https://orcid.org/0000-0001-7571-2385"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jordan Berlin","raw_affiliation_strings":["Vanderbilt-Ingram Cancer Center, Nashville, TN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt-Ingram Cancer Center, Nashville, TN;","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I4390039299"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5016606073","display_name":"Nipun B. Merchant","orcid":"https://orcid.org/0000-0002-3399-9776","observed_orcids":["https://orcid.org/0000-0002-3399-9776"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nipun B. Merchant","raw_affiliation_strings":["Vanderbilt-Ingram Cancer Center, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt-Ingram Cancer Center, Nashville, TN","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I4390039299"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"35","issue":"4_suppl","first_page":"315","last_page":"315"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10760","display_name":"Pancreatitis Pathology and Treatment","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pancreatic-cancer","display_name":"pancreatic cancer","score":0.7020000219345093},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":0.9319999814033508},{"id":"https://openalex.org/keywords/dasatinib","display_name":"dasatinib","score":0.9950000047683716},{"id":"https://openalex.org/keywords/erlotinib","display_name":"erlotinib","score":1.0},{"id":"https://openalex.org/keywords/src-inhibitors","display_name":"Src kinase inhibitor","score":0.7649999856948853},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.7480000257492065},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.8510000109672546},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.781000018119812},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5400000214576721},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.5699999928474426},{"id":"https://openalex.org/keywords/diffusion-weighted-imaging","display_name":"diffusion-weighted imaging","score":0.9350000023841858},{"id":"https://openalex.org/keywords/apparent-diffusion-coefficient","display_name":"apparent diffusion coefficient","score":0.996999979019165},{"id":"https://openalex.org/keywords/tumor-cellularity","display_name":"tumor cellularity","score":0.8679999709129333},{"id":"https://openalex.org/keywords/stable-disease","display_name":"stable disease","score":0.8410000205039978},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.5899999737739563},{"id":"https://openalex.org/keywords/advanced-pancreatic-cancer","display_name":"advanced pancreatic cancer","score":0.6909999847412109},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.46299999952316284},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.5860000252723694},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.8579999804496765}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.928831934928894},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.6588321924209595},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.5541587471961975},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.4923516511917114},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.465970516204834},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.44460198283195496},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.38835522532463074},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3206920623779297},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2017.35.4_suppl.315","doi":"https://doi.org/10.1200/jco.2017.35.4_suppl.315","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2017.35.4_suppl.315","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2761188734","https://openalex.org/W2245598244","https://openalex.org/W2923341767","https://openalex.org/W2039132395","https://openalex.org/W2246281693","https://openalex.org/W2280020748","https://openalex.org/W2329131347","https://openalex.org/W2591335006","https://openalex.org/W2106888561","https://openalex.org/W2284284853"],"abstract_inverted_index":{"315":[0],"Background:":[1],"The":[2,58,346],"combination":[3,371],"of":[4,53,60,68,100,105,117,137,299,313,356,360,365,369,379,395],"E":[5,46,72],"with":[6,45,71,252],"G":[7,27,48,108],"remains":[8],"the":[9,41,66,84,151,157,162,183,194,244,311,393],"only":[10],"approved":[11],"targeted":[12],"therapy":[13],"for":[14,220],"PC":[15,90],"based":[16],"on":[17,109,327],"significant,":[18],"yet":[19],"modest,":[20],"improved":[21],"overall":[22],"survival":[23],"when":[24],"compared":[25],"to":[26,64,82,129,169,187,204,352,387],"alone":[28],"in":[29,50,56,88,134,161,179,193,294,322,325,332,377],"a":[30,118,135,148,228,330,384],"phase":[31],"III":[32],"clinical":[33,389],"trial.":[34],"We":[35],"have":[36],"shown":[37],"previously":[38],"that":[39],"adding":[40],"Src":[42],"inhibitor":[43],"D":[44,69,166,201],"and":[47,73,107,113,130,182,247,280,304,321,362],"resulted":[49],"synergistic":[51],"attenuation":[52],"tumor":[54,333],"growth":[55],"vivo.":[57],"purpose":[59],"this":[61,223,370],"study":[62,78],"was":[63,167,177,185,202,217,232,236,240,301,307,343,350,372],"assess":[65,388],"safety":[67],"given":[70,156],"G.":[74,366],"Methods:":[75],"This":[76],"investigator-initiated":[77],"used":[79],"3+3":[80],"dose-escalation":[81],"determine":[83],"maximum":[85],"tolerated":[86],"dose":[87,153,184,234,349],"advanced":[89],"patients":[91],"(pts).":[92],"Dose":[93],"escalation":[94,235,248],"started":[95],"at":[96,131,150,198,212,340],"70":[97,354],"mg":[98,103,171,206,355,359],"daily":[99,104],"D,":[101,357],"100":[102,205,358],"E,":[106,361],"days":[110],"1,":[111],"8,":[112],"15":[114],"(800":[115],"mg/m2)":[116],"28-day":[119],"cycle.":[120],"Diffusion-weighted":[121],"MRI":[122,328],"(DW-MRI)":[123],"measurements":[124],"(ADC)":[125],"were":[126,143,191,210,259,287],"collected":[127],"prior":[128],"four":[132,196],"weeks":[133,342],"subset":[136],"pts":[138,142,181,197,209,226,317],"(n=3).":[139],"Results:":[140],"Nineteen":[141],"enrolled.":[144],"One":[145],"pt":[146,216],"experienced":[147,227],"DLT":[149,176],"starting":[152],"(L0);":[154],"however,":[155],"side":[158],"effects":[159],"observed":[160,178,192,373],"first":[163],"two":[164,316],"pts,":[165],"reduced":[168],"50":[170],"(L-1).":[172],"At":[173,310],"L-1,":[174],"one":[175,215],"1/6":[180,225],"re-escalated":[186],"L0.":[188],"Zero":[189,285],"DLTs":[190],"next":[195],"L0":[199],"thus":[200],"escalated":[203],"(L1).":[207],"Seven":[208],"treated":[211],"L1":[213,231],"as":[214,238,374],"not":[218],"evaluable":[219],"safety.":[221],"In":[222],"cohort,":[224],"DLT.":[229],"Although":[230],"tolerable,":[233],"stopped":[237],"it":[239],"felt":[241],"L1was":[242],"within":[243],"therapeutic":[245,336],"window":[246],"would":[249],"enhance":[250],"toxicity":[251],"minimal":[253],"benefit.":[254],"Most":[255],"frequent":[256],"toxicities":[257],"(%)":[258],"anemia":[260],"(89),":[261],"elevated":[262,270],"aspartate":[263],"aminotransferase":[264,272],"(79),":[265,267,269],"fatigue":[266],"nausea":[268],"alanine":[271],"(74),":[273,275,277],"lymphopenia":[274],"leukopenia":[276],"neutropenia":[278],"(63),":[279,282],"thrombocytopenia":[281],"most":[283,347],"Gr1/2.":[284],"responses":[286],"observed,":[288],"but":[289],"disease":[290,338],"stabilization":[291],"(SD)":[292],"occurred":[293,376],"9/13":[295],"(69%).":[296],"Median":[297],"duration":[298],"SD":[300,375],"4":[302],"months,":[303],"median":[305],"OS":[306],"7.7":[308],"mos.":[309],"time":[312],"data":[314],"cutoff,":[315],"are":[318],"still":[319],"alive":[320],"follow-up.":[323],"Increase":[324],"ADC":[326],"reflected":[329],"decrease":[331],"cellularity":[334],"suggesting":[335],"benefit;":[337],"assessment":[339],"8":[341],"SD.":[344],"Conclusions:":[345],"tolerable":[348],"determined":[351],"be":[353,383],"800":[363],"mg/m2":[364],"Clinical":[367,397],"activity":[368],"69%":[378],"pts.":[380],"DW-MRI":[381],"could":[382],"promising":[385],"technique":[386],"benefit":[390],"early":[391],"during":[392],"course":[394],"therapy.":[396],"trial":[398],"information:":[399],"NCT01660971.":[400]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2017-04-07T00:00:00"}